0.6811
price down icon0.88%   -0.0182
 
loading
Dermata Therapeutics Inc stock is traded at $0.6811, with a volume of 21,533. It is down -0.88% in the last 24 hours and up +10.80% over the past month. Dermata Therapeutics Inc is a late-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its two product candidates, XYNGARI (formerly known as DMT310) and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Dermata announced positive Phase 3 data from its STAR-1 clinical trial in March 2025.
See More
Previous Close:
$0.6993
Open:
$0.708
24h Volume:
21,533
Relative Volume:
0.16
Market Cap:
$4.34M
Revenue:
-
Net Income/Loss:
$-11.27M
P/E Ratio:
-0.0318
EPS:
-21.4132
Net Cash Flow:
$-9.40M
1W Performance:
+5.95%
1M Performance:
+10.80%
6M Performance:
-40.76%
1Y Performance:
-73.13%
1-Day Range:
Value
$0.681
$0.71
1-Week Range:
Value
$0.6415
$0.75
52-Week Range:
Value
$0.5739
$3.79

Dermata Therapeutics Inc Stock (DRMA) Company Profile

Name
Name
Dermata Therapeutics Inc
Name
Phone
(858)-223-0882
Name
Address
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Name
Employee
8
Name
Twitter
Name
Next Earnings Date
2024-08-15
Name
Latest SEC Filings
Name
DRMA's Discussions on Twitter

Compare DRMA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
DRMA
Dermata Therapeutics Inc
0.6811 4.56M 0 -11.27M -9.40M -21.41
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.31 122.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.19 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.49 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
594.16 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
292.16 31.91B 3.81B -644.79M -669.77M -6.24

Dermata Therapeutics Inc Stock (DRMA) Latest News

pulisher
07:23 AM

Should I buy Dermata Therapeutics Inc. stock before earningsTremendous wealth creation - jammulinksnews.com

07:23 AM
pulisher
04:33 AM

What drives Dermata Therapeutics Inc. stock priceSky-high return potential - Autocar Professional

04:33 AM
pulisher
04:30 AM

Is Dermata Therapeutics Inc. a good long term investmentGame-changing returns - Autocar Professional

04:30 AM
pulisher
12:34 PM

What drives Dermata Therapeutics Inc. Equity Warrant stock priceConsistent triple returns - Autocar Professional

12:34 PM
pulisher
Jul 24, 2025

What analysts say about Dermata Therapeutics Inc. Equity Warrant stockHigh-yield market plays - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Dermata Therapeutics Inc. stockFree Trend-Following Techniques - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Dermata Therapeutics Inc. Equity Warrant a good long term investmentHigh-profit trading signals - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 22:23:22 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Dermata Therapeutics Inc. Stock Analysis and ForecastBreakthrough profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

Dermata Therapeutics Inc. Equity Warrant Stock Analysis and ForecastRecord-breaking capital gains - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 16, 2025

Dermata Therapeutics shareholders approve reverse stock split and key proposals By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 16, 2025

Dermata Therapeutics shareholders approve reverse stock split and key proposals - Investing.com

Jul 16, 2025
pulisher
Jul 16, 2025

Dermata Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Dermata Therapeutics Inc. stock price move sharplyPro Trader Stock Focus - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Dermata Therapeutics Inc. Equity Warrant stock performs during market volatilityFree Membership Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Dermata Therapeutics Inc. Equity Warrant stock price move sharplyFree Stock Tips Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Dermata Therapeutics Inc. stock attracts strong analyst attentionExpert Backed Predictions - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Dermata Therapeutics Inc. Equity Warrant stock attracts strong analyst attentionFree Exclusive Investment Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Dermata Therapeutics Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser

Jul 15, 2025

Dermata Therapeutics Inc Stock (DRMA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.29
price down icon 1.74%
$36.50
price up icon 0.00%
$103.56
price down icon 0.03%
$27.38
price down icon 0.69%
$113.86
price down icon 0.68%
biotechnology ONC
$288.37
price down icon 2.39%
Cap:     |  Volume (24h):